PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.\', \'Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University Vienna, Vienna, Austria.\', \'Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.\', \'Second Medical Department, Lower Austrian Centre for Rheumatology, Stockerau, Austria.\', \'Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria stephan.blueml@meduniwien.ac.at.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2021-221347
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 34844927
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all